![Armand Keating](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Armand Keating
Directeur/Membre du Conseil chez
Tissue Regeneration Therapeutics, Inc.
Fortune : 14 696 $ au 31/12/2025
Profil
Armand Keating is the founder of panCELLa, Inc. (2015).
Dr. Keating is currently a Director at Tissue Regeneration Therapeutics, Inc. and a Director at Pancella Therapeutics, Inc. Former jobs include Professor at the University of Toronto, President of the American Society of Hematology, President of the American Society for Blood & Marrow Transplantation, Chief Medical Services at Princess Margaret Hospital, and Chief Medical Officer at Roquefort Therapeutics Plc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 0,18% | 31/01/2025 | 156 740 ( 0,18% ) | 14 696 $ | 31/12/2025 |
Postes actifs de Armand Keating
| Sociétés | Poste | Début |
|---|---|---|
Tissue Regeneration Therapeutics, Inc.
 Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Develops human umbilical cord perivascular cells and other therapy products | Directeur/Membre du Conseil | - |
Anciens postes connus de Armand Keating
| Sociétés | Poste | Fin |
|---|---|---|
Pancella Therapeutics, Inc.
 Pancella Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for genodermatoses | Directeur/Membre du Conseil | 04/07/2022 |
Princess Margaret Hospital
 Princess Margaret Hospital Part of Royal Group (United Arab Emirates), Princess Margaret Hospital Dental oncology is a company that specializes in dental oncological and maxillofacial prosthetics, with a focus on head and neck cancer, chemotherapy, malignant hematology, osteonecrosis/MRONJ, and medication-related osteoradionecrosis of the jaw (MRONj). Princess Margaret Hospital offers palliative care and have a High-Risk Oral Lesion Clinic. The clinic is staffed by a team of full-time dentists, clinical associates, clinical fellows, consultants, and support staff. The company is based in Toronto, Canada. The company was founded by David Alexander MacNicol. The CEO is Cho-Ze Joseph Lui. | Directeur Technique/Scientifique/R&D | - |
American Society for Blood & Marrow Transplantation
 American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. | President | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | President | - |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Tissue Regeneration Therapeutics, Inc.
Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Develops human umbilical cord perivascular cells and other therapy products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. | |
Princess Margaret Hospital
Princess Margaret Hospital Part of Royal Group (United Arab Emirates), Princess Margaret Hospital Dental oncology is a company that specializes in dental oncological and maxillofacial prosthetics, with a focus on head and neck cancer, chemotherapy, malignant hematology, osteonecrosis/MRONJ, and medication-related osteoradionecrosis of the jaw (MRONj). Princess Margaret Hospital offers palliative care and have a High-Risk Oral Lesion Clinic. The clinic is staffed by a team of full-time dentists, clinical associates, clinical fellows, consultants, and support staff. The company is based in Toronto, Canada. The company was founded by David Alexander MacNicol. The CEO is Cho-Ze Joseph Lui. | |
Pancella Therapeutics, Inc.
Pancella Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for genodermatoses | Health Technology |
panCELLa, Inc.
 panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops iPSC-derived macrophage cell therapy for inflammatory organ diseases | Commercial Services |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
